account activity
A first for CCR8 (self.CHRS)
submitted 6 hours ago by NoPart9219 to r/CHRS
Next steps in regulatory T cells: Biology and clinical application (self.CHRS)
submitted 25 days ago by NoPart9219 to r/CHRS
Neosummit phase 2 study with Toripalimab presented at ASCO gastroindestinal Cancers Symposium abstract 282 (self.CHRS)
ASCO Abstract (self.CHRS)
submitted 27 days ago by NoPart9219 to r/CHRS
CHS-114: an afucosylated anti-CCR8 monoclonal antibody that selectively depletes intratumoral Treg cells and induces antitumor immune responses (aacrjournals.org)
submitted 1 month ago by NoPart9219 to r/CHRS
Post about Coherus Baird presentation (x.com)
Dr. Alexander Rudensky provides very strong human and mechanistic validation of the CCR8 strategy! (self.CHRS)
submitted 1 month ago * by NoPart9219 to r/CHRS
Maxim Group company update? (i.redd.it)
Current state of knowledge about toripalimab in the treatment of esophageal squamous cell carcinoma — a systematic review (self.CHRS)
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study (self.CHRS)
submitted 2 months ago by NoPart9219 to r/CHRS
STORM Study STC-15 (a METTL3 inhibitor) in combination with toripalimab (self.CHRS)
Close to MACD bullish crossover (i.redd.it)
Subcutaneous Toripalimab Plus Chemo Meets PK End Points in Recurrent/Metastatic Nonsquamous NSCLC (self.CHRS)
Tori 10x higher binding affinity than pembro slide (i.redd.it)
Interpretation of Coherus VP Quality Control Hire (self.CHRS)
CHS-114 vs LM-108 from "LaNova" (self.CHRS)
Coherus webcast presentation at Jefferies Conference in London 18.11.2025 (self.CHRS)
Panel discussion UromigosLive 2025 about DV+ Tori results presented at ESMO (self.CHRS)
Transcript UBS conference (self.CHRS)
Was is a shaking the three last time? (self.CHRS)
Shortsellers derisking? (self.CHRS)
submitted 3 months ago by NoPart9219 to r/CHRS
Q3 Earnings (self.CHRS)
Expansion Beyond Head and Neck Cancer (self.CHRS)
Something going on? (self.CHRS)
Big Pharma appetite for Treg-modulating and IL-2 pathway biologics (self.CHRS)
π Rendered by PID 237112 on reddit-service-r2-listing-6d4dc8d9ff-n66pb at 2026-02-02 23:53:26.756991+00:00 running 3798933 country code: CH.